International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia

NCT02724163 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

700

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukaemia

Interventions

DRUG: Gemtuzumab ozogamicin
DRUG: Liposomal daunorubicin
DRUG: Mitoxantrone
DRUG: Fludarabine
DRUG: Cytarabine
DRUG: Busulfan
DRUG: Cyclophosphamide

Sponsor

University of Birmingham

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]